Joseph

Switzerland
|
2022-2024
  • Adults (18-64 years)
  • General population
  • Elderly (≥65 years)
  • Hospital
  • Respiratory syncytial virus
  • Respiratory syncytial virus infection

Lihou

United Kingdom
|
2022-2023
  • Adults (18-64 years)
  • General population
  • Elderly (≥65 years)
  • Hospital
  • Respiratory syncytial virus
  • Respiratory syncytial virus infection

M-BOOST-FR

France
|
2025-2027
  • Adults (18-64 years)
  • Elderly (≥65 years)
  • People at high risk of STIs
  • Men who have sex with men
  • PrEP users
  • Outpatient clinic
  • Monkeypox virus
  • Mpox
  • Sexually transmitted infection
  • Serum
  • Pharmacological intervention
  • Vaccination
  • MVA-BN

Crandell

Portugal Brazil
|
2022-2023
  • Adults (18-64 years)
  • General population
  • Elderly (≥65 years)
  • Outpatient clinic
  • Monkeypox virus
  • Mpox
  • Sexually transmitted infection
  • Blood sample
  • PBMC
  • Pharmacological intervention
  • Vaccination
  • JYNNEOS
  • Dryvax

Packer

United Kingdom
|
2022-2022
  • Adults (18-64 years)
  • General population
  • Elderly (≥65 years)
  • Adolescents (12-17 years)
  • Children (1-11 years)
  • Community
  • Monkeypox virus
  • Mpox
  • Sexually transmitted infection

VaQDENV

Italy
|
2024-2028
  • Adults (18-64 years)
  • General population
  • Elderly (≥65 years)
  • Adolescents (12-17 years)
  • Children (1-11 years)
  • Outpatient clinic
  • Arbovirus
  • Dengue virus
  • Vector-borne disease
  • Arboviral disease
  • Vector-borne disease
  • Blood sample
  • Pharmacological intervention
  • Vaccination
  • Qdenga

SeVIHPrEP

Spain
|
2020-2030
  • Adults (18-64 years)
  • Elderly (≥65 years)
  • People at high risk of STIs
  • Men who have sex with men
  • PrEP users
  • Non-hospital health centre
  • STD/STI clinic
  • Chlamydia trachomatis
  • Neisseria gonorrhoeae
  • Treponema pallidum
  • HIV
  • Mycoplasma genitalium
  • Hepatitis
  • Sexually transmitted infection
  • Anal-rectal swab
  • Oral swab
  • Urethral exudate
  • Pharmacological intervention
  • PrEP-HIV

EpGAr

France
|
2024-2025
  • Adults (18-64 years)
  • Elderly (≥65 years)
  • Adolescents (12-17 years)
  • Children (1-11 years)
  • Hospital
  • Neisseria gonorrhoeae
  • Sexually transmitted infection

DanPrEPD

Denmark
|
2022-2022
  • Adults (18-64 years)
  • Elderly (≥65 years)
  • People at high risk of STIs
  • Men who have sex with men
  • PrEP users
  • Primary care
  • Non-hospital health centre
  • STD/STI clinic
  • Chlamydia trachomatis
  • Neisseria gonorrhoeae
  • Treponema pallidum
  • Sexually transmitted infection
  • Syphilis
  • Pharmacological intervention
  • Antivirals
  • PrEP-HIV

SwissPrEPared

Switzerland
|
2019-2022
  • Adults (18-64 years)
  • Elderly (≥65 years)
  • People at high risk of STIs
  • PrEP users
  • Hospital
  • Community
  • Primary care
  • Chlamydia trachomatis
  • Neisseria gonorrhoeae
  • Treponema pallidum
  • Sexually transmitted infection
  • Syphilis
  • Pharmacological intervention
  • PrEP-bSTI

Velay

France
|
2024-2025
  • Adults (18-64 years)
  • Elderly (≥65 years)
  • Travelers
  • Hospital
  • Emergency department
  • Arbovirus
  • Chikungunya virus
  • Vector-borne
  • Dengue virus
  • Zika virus
  • Arboviral disease
  • Vector-borne disease

ITIT

Switzerland
|
2022-2025
  • Adults (18-64 years)
  • Elderly (≥65 years)
  • Travelers
  • Community
  • Telemedicine
  • Arbovirus
  • Chikungunya virus
  • Vector-borne
  • Dengue virus
  • West Nile virus
  • Arboviral disease
  • Vector-borne disease
  • Post-acute infection syndrome
  • Non pharmacological intervention
  • Digital health